AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

DRIO · NASDAQ · Medical - Specialties

DarioHealth

Combines connected devices, software, and coaching for chronic-condition care.

$6.77

After-hours close+0.27 (+4.15%)

At close$6.50(−3.99%)

Something off on this page? Send us feedback.

Profile

DarioHealth Corp.DRIOHealth Care

Provides digital care for cardiometabolic and behavioral-health needs through connected devices, software, coaching, and support. Employers and health plans primarily offer the services to eligible members through a B2B2C model; the company reports one operating segment.

Combines digital engagement, connected devices, condition monitoring, coaching, communications, analytics, alerts, and support for cardiometabolic and behavioral-health needs. Its deployed solutions cover diabetes, hypertension, pre-diabetes, musculoskeletal care, and behavioral health. The offering expanded from diabetes support into a multi-condition platform.

Revenue primarily comes through B2B2C arrangements: employers, health plans, and other enterprise customers offer the services to eligible members. Providers and pharmaceutical companies are also customers, while retained direct-to-consumer activity in the United States and selected international markets tests features before enterprise deployment. Acquisitions, including Twill, expanded the platform’s digital-led-care capabilities. The company reports one operating segment.

Company facts

CEOErez Raphael

ListedApr 9, 2013

ExchangeNASDAQ

HeadquartersNew York, NY

CountryUnited States

Employees160

CIK0001533998

ISINUS23725P3082

Key statistics

Market cap$49.5M

EPS (ttm)$0.6900

P/E (ttm)9.81

ROE104.1%

P/B1.15

P/S2.36

Dividend yield—

Beta0.26vs XLV 0.04

Year to date −38.2% · Average volume (30d) 29.4K

Analysts

Price target, next 12 months$14.00+106.8%Median of 9 analysts · vs the Aug 28 close

ConsensusBuy8 of 9 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $6.77

High$16.00+136.3%

Median$14.00+106.8%

Low$7.50+10.8%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Target
Nov 14, 2025	Stifel Nicolaus	Target	$16

Earnings

EPS

Estimate−$0.95

ReportedDue Nov 12, 2026

Revenue

Estimate$5.2M

ReportedDue Nov 12, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 11, 2026Q2 FY26	−$1.22	−$0.85	+30.3%	$5.9M	$5.2M	−12.6%	+0.13%
May 13, 2026Q1 FY26	−$1.09	−$0.81	+25.7%	$5.5M	$5.6M	+2.3%	+3.58%
Mar 19, 2026Q4 FY25	−$2.44	−$0.80	+67.2%	$5.0M	$5.2M	+3.0%	−3.03%
Nov 13, 2025Q3 FY25	−$2.63	−$1.85	+29.7%	$5.0M	$5.0M	−0.8%	+18.25%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$6.8M	$5.4M	$5.0M	$5.2M	$5.6M	$5.2M
Gross profit	$3.9M	$3.4M	$3.0M	$2.4M	$3.2M	$3.2M
Operating income	$9.4M	$9.2M	−$9.5M	−$45.8M	−$7.3M	−$6.5M
Net income	−$9.2M	−$13.0M	−$2.1M	$86.0M	−$8.2M	−$7.9M
Diluted EPS	−$0.31	−$0.20	−$0.19	$1.90	−$0.17	−$0.85
Gross margin	57.5%	63.3%	60.2%	45.3%	57.3%	61.7%
Operating margin	139.4%	171.4%	-189.4%	-875.2%	-130.9%	-125.1%

Fiscal years (4-quarter sums)FY21 $20.5M · FY22 $27.7M · FY23 $20.4M · FY24 $27.0M · FY25 $22.4M

Revenue by product · Q2 FY26

Service$2.6M · 100%

Balance sheet, Jun 30, 2026Cash & short-term investments $14.3M · Total debt $32.4M · Total assets $96.6M · Shareholders' equity $55.1M

Dividends

No dividends on record.

Ownership

Institutions 11.52%842.6K sharesInsiders 5.80%424.0K sharesOther 82.68%6.05M shares

Shares outstanding 7.31M · Float 5.19M · 71.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Tasso Partners, LLC	676.1K	9.99%	13G	Nov 12, 2025
Craig Kallman 2015 Living Trust	675.2K	9.99%	13G	Dec 16, 2025
Nantahala Capital Management, LLC	610.7K	8.35%	13F	May 15, 2026
Erez Raphael · director, officer: Chief Executive Officer	156.9K	2.15%	Form 4	Sep 15, 2025
Vanguard Capital Management LLC	65.9K	0.90%	13F	May 15, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Jul 23, 2026	Dennis Matheis	director	+14,430	$6.93